These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 26047796)

  • 1. Current and next generation influenza vaccines: Formulation and production strategies.
    Soema PC; Kompier R; Amorij JP; Kersten GF
    Eur J Pharm Biopharm; 2015 Aug; 94():251-63. PubMed ID: 26047796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in development of the influenza vaccine with broader cross-protection.
    Stropkovská A; Janulíková J; Varecková E
    Acta Virol; 2010; 54(1):7-19. PubMed ID: 20201609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation development of a plant-derived H1N1 influenza vaccine containing purified recombinant hemagglutinin antigen.
    Iyer V; Liyanage MR; Shoji Y; Chichester JA; Jones RM; Yusibov V; Joshi SB; Middaugh CR
    Hum Vaccin Immunother; 2012 Apr; 8(4):453-64. PubMed ID: 22370514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of cell culture-based influenza vaccine production.
    Perdue ML; Arnold F; Li S; Donabedian A; Cioce V; Warf T; Huebner R
    Expert Rev Vaccines; 2011 Aug; 10(8):1183-94. PubMed ID: 21854311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccines: a moving interdisciplinary field.
    Schotsaert M; García-Sastre A
    Viruses; 2014 Oct; 6(10):3809-26. PubMed ID: 25302957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains.
    Jang YH; Lee EY; Byun YH; Jung EJ; Lee YJ; Lee YH; Lee KH; Lee J; Seong BL
    Vaccine; 2014 Jan; 32(5):535-43. PubMed ID: 24342248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration.
    Patil HP; Murugappan S; de Vries-Idema J; Meijerhof T; de Haan A; Frijlink HW; Wilschut J; Hinrichs WL; Huckriede A
    Eur J Pharm Biopharm; 2015 Jun; 93():231-41. PubMed ID: 25896446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice.
    Harada Y; Ninomiya-Mori A; Takahashi Y; Shirakura M; Kishida N; Kageyama T; Tada Y; Tashiro M; Odagiri T
    Vaccine; 2011 Oct; 29(46):8330-7. PubMed ID: 21911027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How far have we reached in development of effective influenza vaccine?
    Looi QH; Foo JB; Lim MT; Le CF; Show PL
    Int Rev Immunol; 2018; 37(5):266-276. PubMed ID: 30252547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets.
    Stittelaar KJ; Veldhuis Kroeze EJ; Rudenko L; Dhere R; Thirapakpoomanunt S; Kieny MP; Osterhaus AD
    Vaccine; 2011 Nov; 29(49):9265-70. PubMed ID: 21945964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in new vaccine strategies against influenza: a review].
    Liu Z; Jiang T; Qin E; Ran D; Qin C
    Sheng Wu Gong Cheng Xue Bao; 2012 May; 28(5):550-6. PubMed ID: 22916493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vaccines and chemicals for the prevention of influenza].
    Gendon IuZ
    Vopr Virusol; 2007; 52(1):4-10. PubMed ID: 17338227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.
    van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Vogelzang-van Trierum SE; Nieuwkoop NJ; van de Vijver DA; Fouchier RA; Osterhaus AD; Morein B; Rimmelzwaan GF
    Vaccine; 2014 Sep; 32(43):5614-23. PubMed ID: 25140929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different influenza vaccine formulations and adjuvants for childhood influenza vaccination.
    Esposito S; Principi N
    Vaccine; 2011 Oct; 29(43):7535-41. PubMed ID: 21820478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope-based vaccine against influenza.
    Ben-Yedidia T; Arnon R
    Expert Rev Vaccines; 2007 Dec; 6(6):939-48. PubMed ID: 18034655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: the importance of cross-protection.
    Ansaldi F; Canepa P; Parodi V; Bacilieri S; Orsi A; Compagnino F; Icardi G; Durando P
    Vaccine; 2009 May; 27(25-26):3345-8. PubMed ID: 19200846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDCK cell-cultured influenza virus vaccine protects mice from lethal challenge with different influenza viruses.
    Liu K; Yao Z; Zhang L; Li J; Xing L; Wang X
    Appl Microbiol Biotechnol; 2012 Jun; 94(5):1173-9. PubMed ID: 22415544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccines: from whole virus preparations to recombinant protein technology.
    Huber VC
    Expert Rev Vaccines; 2014 Jan; 13(1):31-42. PubMed ID: 24192014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections.
    Liu G; Song L; Reiserova L; Trivedi U; Li H; Liu X; Noah D; Hou F; Weaver B; Tussey L
    Vaccine; 2012 Nov; 30(48):6833-8. PubMed ID: 23000130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant vaccines for influenza virus.
    Tripp RA; Tompkins SM
    Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.